Come up with a name for your new list and we'll add to it:
Enumeral Biomedical raised a round of funding on May 07, 2014. Investors include
Harris & Harris Group.
Enumeral Biomedical engages in the discovery of native human monoclonal antibodies for use in the diagnosis and treatment of infectious, autoimmune and inflammatory diseases. The company's microengrav…